Erythropoietin against infarction
A single intravenous injection of the hormone erythropoietin (EPO) immediately after inarct can minimize the process of apoptosis and thereby limit damage to cardiac tissues.
10.10.2008A single intravenous injection of the hormone erythropoietin (EPO) immediately after inarct can minimize the process of apoptosis and thereby limit damage to cardiac tissues.
10.10.2008The head of the laboratory "Genomic Medicine" of the clinic of the NEFU Medical Institute, Nadezhda Maksimova, informed the Ogonek magazine about the discovery of a new genetic disease in Yakutia.
19.10.2015The parties will join efforts to organize the practical use of nanotechnology in medicine – to create new medicines, methods of treatment and prevention of diseases. In particular, Rosnanotech Group and the Russian Academy of Medical Sciences plan to cooperate in conducting research and development in healthcare based on nanotechnology and their commercialization.
10.07.2008In three years, the proceeds of a thriving funeral home from the evisceration of corpses amounted to almost five million dollars. Donor organs with fictitious permits of relatives of the deceased were sent to various medical centers in the USA and Canada.
01.07.2008Six new biotechnological laboratories will be opened at St. Petersburg Polytechnic University by the end of the year. They will be headed by Russians who have long gone abroad, and now have decided to work at home.
08.10.2014Japanese doctors removed the lower lobe of the mother's left lung and, having "constructed" smaller left and right lungs from this tissue, performed an operation to transplant a new organ to a two-year-old child.
26.09.2014Russia will create a domestic robot for surgery, the development of which will take four years.
04.06.2014Last year, 1,103 series of substandard drugs were withdrawn from circulation in Russia – 3.8% of all tested. About 60% were medicines of domestic production.
19.05.2014Drug development begins with the synthesis of the drug, then the drug undergoes preclinical trials (on animals), clinical trials (on humans, phases I - III), and only after that it goes on sale.
29.04.2008Herceptin (trastuzumab) in combination with standard chemotherapy before surgery for breast cancer leads to complete eradication of the tumor in 45.5% of women, whereas in those who received only chemotherapy – in 30%.
21.04.2008Russian business is not motivated to consume innovations. This opinion was expressed by the President of the Chamber of Commerce and Industry of the Russian Federation Sergey Katyrin, speaking at the international economic forum in Strasbourg, France.
28.06.2011Older people are more at risk of skin cancer and infections because their skin is not able to mobilize the immune system to protect the body.
31.08.2009After kidney transplantation, the patient has to undergo a painful biopsy procedure every six months, or even more often. The Russian Scientific Center of Surgery has developed a method for determining the danger of rejection of a transplanted kidney by protein markers in urine.
26.06.2009In 2008, pharmaceutical and biotech companies in the United States spent a record amount on scientific research.
07.04.2009The Los Angeles IVF center is expecting the birth of the first child with the specified characteristics next year.
03.03.2009You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.